Scottish Health Innovations Ltd (SHIL) works in partnership with NHS Scotland to identify, protect, develop and commercialise new innovations from healthcare professionals. Registered Number: SC 236303. Registered address: The Golden Jubliee National Hospital, Fourth Floor East, Agmemmon St, Clydebank, G81 4DY
News & Events
Stay up to date with latest activity at SHIL
NHS Clinical Entrepreneurs Series - Dundee
The NHS Clinical Entrepreneurs Series will harness entrepreneurial talent across NHS Scotland to equip health professionals with the skills, knowledge and support to translate innovative ideas into commercial success.
Clinical Entrepreneurs Series - Dundee - Wednesday 27 March - Programme
Speakers and profiles
Graham Watson, Executive Chairman, Scottish Health Innovations Ltd. (SHIL)
Graham Watson LLB CA FRSA is an experienced non-executive director with a strong commercial track record. He has a rich mix of recent non-executive and advisory responsibilities in Scotland, covering The Law Society of Scotland (where he is a member of Council), the Court of Heriot-Watt University (where he also chairs the Finance Committee), Scottish Futures Trust and North Lanarkshire Leisure Limited (where he also chaired the Audit Committee). He is a former partner in a Big 4 accounting firm, with extensive experience of working with SME clients delivering business development and strategic planning programmes and leading change initiatives. During his career, he has initiated and executed over 100 corporate transactions, valued at over £2bn. He has lived and worked in Silicon Valley, as well as in Scotland, during his 35-year business career.
Dr Robert Rea, Head of Innovation, Scottish Health Innovations Ltd. (SHIL)
Robert Rea holds a BSc (Hons) Developmental Biology, University of Edinburgh, (1998). He completed a PhD in Biology from the University of York in 2002, specifically in genetics of plant cell division, and completed post-doctoral research fellowships at Walter & Eliza Hall Institute, Melbourne, Australia in dendritic cell immunology, 2003-2004. After that, Robert worked at the University of Queensland, Brisbane, Australia developing novel stem cell-based therapies for kidney disease between 2004-2006. Robert became Automation Manager for Swedish biotech company Cellartis in 2007 and became Intellectual Property Manager for French biotech company Cellectis in 2010. He held the position of Business Development Executive at the University of St Andrews from 2013-2014, before joining SHIL as Head of Innovation in 2014.
Jean Ngoie, Head of Instrumentation and Clinical Engineering NHS Tayside
Jean is the Head of Instrumentation and Clinical Engineering in NHS Tayside, Dundee. He has more than 20 years of healthcare technology management experience. He spent most of his career between Healthcare and Industry. With approximately 16 of these years spent at Guy’s & St Thomas’ Hospital NHS Trust (London), The Hospital for Sick Children (Toronto, Canada), Niagara Health (Niagara, Canada) and Smiths Medical (global company). Jean is currently a Senior Lecturer in Biomedical Engineering at The University of Dundee, School of Science and Engineering. Jean is a Chartered Engineer with keen interest in disruptive healthcare innovation and life Science.
Brian McNicoll, Head of Centre of Entrepreneurship, University of Dundee
Graduating from the School of Computing at the University of Dundee in 2003 Brian went on to found the BAFTA-award winning mobile/social game company Dynamo Games growing a profitable and successful business to a team of 25, spearheading the creative and technical production of more than 40 digital products that had over 1 million downloads. In 2012 Brian exited the business and moved on to be Business Partnership Manager for Design in Action – a £4m Art and Humanities Research Council-funded Knowledge Exchange project. Brian’s role in the project was to manage the portfolio of design-led businesses that the project funded and these businesses have generated 81 jobs and are currently projected to hit a cumulative turnover (since 2013) of over £12.4m later this year. Brian began his new post at the University of Dundee in July 2016 driving forward the Enterprise and Entrepreneurship agenda for staff, students and alumni and helping to establish the institution’s exciting new Centre of Entrepreneurship.
John Dillon, Professor of Hepatology and Gastroenterology, University of Dundee & NHS Research Scotland Hepatology Clinical Lead
John is Professor of Hepatology and Gastroenterology and a principle investigator, in the Division of Molecular and Clinical Medicine, School of Medicine, the University of Dundee, based at Ninewells Hospital, Dundee. He is also an Honorary Consultant with NHS Tayside, leading a busy general hepatology service and a research group. He graduated in medicine from St Georges Hospital Medical School, University of London, and subsequently gained his MD based on research performed in the University of Edinburgh while a lecturer in Gastroenterology and Hepatology. His research interests include; new pathways of care for patients with abnormal LFTs, for people infected with HCV, new therapies for HCV infection, as well as novel diagnostics and treatments for NAFLD. His research activities stretch from the bench to the bedside and out into the community. He has published over 150 peer-reviewed original research papers. He chairs the Scottish HCV Action Plan Clinical Leads Group, is a member of the Scottish Government’s Ministerial advisory board for Blood Borne Viruses and sexual health and is the President of the Scottish Society of Gastroenterology. He previously lead the development group of the UK consensus guidelines for HCV and has chaired the Hepatitis C SIGN guideline development group. He Chaired the SHAAP group that produced the recent “Alcohol-related liver disease: guidance for good practice” documents and is currently President of the Scottish Society for Gastroenterology.
Graeme Houston, Professor and Chair of Clinical Imaging and Intervention, University of Dundee & Non-Executive Medical Director, Vascular Flow Technologies
Graeme Houston qualified in Natural Sciences in 1983, and MB Bchir in 1987 from Cambridge University, developing an interest in Clinical Imaging and was appointed Professor of Clinical Imaging in the University of Dundee in 2009 and Co-Director of the Clinical Research Imaging Facility. A Consultant Radiologist at Ninewells Hospital and Medical School Dundee, since 1995, he has focused on developing and implementing services in MRI and Interventional Radiological techniques particularly in relation to cardiovascular disease following Clinical Fellowship in radiology at the University of British Columbia, Vancouver, Canada. His major research interests are the improvement of non-invasive methods of assessing patient risk factors for disease, the development of new image-guided treatments, and the use of imaging techniques to improve understanding of the pathophysiology of cardiovascular disease. My current research is distinctly collaborative both locally, nationally and internationally with funded multi-centre clinical, and pre-clinical trials. Spare time spent sailing skiing and mountain biking with family and friends.
Dr Debbie Wake, Co-founder and CEO of MyWay Digital Health and national clinical lead for MyDiabetesMyWay
Dr Debbie Wake, Co-founder and CEO of MyWay Digital Health, a successful University of Dundee spin out company (incorporated Jan 2017) from the School of Medicine. Now the company has 15 employees, turning over £1m and significant commercial contracts in NHS England and a strong pipeline developing in the Middle East and the USA. She is also a Clinical Reader at the Centre for Medical Informatics, Usher Institute, University of Edinburgh (UoE), NHS Diabetes Consultant (NHS Lothian), (MBChB, BSc, PhD, Clin Ed Dip). Debbie is passionate about technology, informatics and educational in diabetes care. She is the national clinical lead for MyDiabetesMyWay - a data-driven self-management platform for people with diabetes with more than 40,000 registrants. Her business is the winner of the European e-health adopters award in 2017 (DUK self-management award).
Debbie Wake is currently leading a £1m multi-stakeholder Innovate UK Digital Health Technology Catalyst to support artificial intelligence in diabetes care. Furthermore, Debbie is a 2017/18 NHS Innovation Accelerator fellow, a 2015 Diabetes UK Clinical Champion, an Innovate UK Women in Innovation Award winner. Debbie was a health columnist for the Scotsman newspaper (2008-11), and resident on-screen doctor for STV (The Hour) (2009-11).
Venue and directions
The Clinical Entrepreneurs Series - Dundee workshop will take place at:
West Park Conference Centre
319 Perth Road
West Park Conference and Events Centre is located in the West End of Dundee, offering exceptional customer service with outstanding modern facilities.